Subclinical impairment of brain function in chronic hepatitis C infection. (Q48512959)

12 February 2018

title

Subclinical impairment of brain function in chronic hepatitis C infection. (English)

1 reference

12 February 2018

1 reference

1 reference

1 reference

Ludwig Kramer

1

1 reference

12 February 2018

Edith Bauer

2

1 reference

12 February 2018

Georg Funk

3

1 reference

12 February 2018

Harald Hofer

4

1 reference

12 February 2018

Wolfgang Jessner

5

1 reference

12 February 2018

Petra Steindl-Munda

6

1 reference

12 February 2018

Friedrich Wrba

7

1 reference

12 February 2018

Christian Madl

8

1 reference

12 February 2018

Alfred Gangl

9

1 reference

12 February 2018

Peter Ferenci

10

1 reference

12 February 2018

publication date

1 September 2002

1 reference

12 February 2018

published in

Journal of Hepatology

1 reference

12 February 2018

volume

37

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

page(s)

349-354

1 reference

12 February 2018

Morbidity of chronic hepatitis C as seen in a tertiary care medical center

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Evidence for a cerebral effect of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

The impact of diagnosis of hepatitis C virus on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Beneficial effect of renal transplantation on cognitive brain function.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Signs of cognitive change in HIV disease: an event-related brain potential study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

1 reference

7 January 2021

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Grip strength and subjective fatigue in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Neurophysiology of postiviral fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Is fatigue associated with cholestasis mediated by altered central neurotransmission?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

Impaired health-related quality of life in chronic hepatitis C: the how, but not the why.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900172-1

7 January 2021

10.1016/S0168-8278(02)00172-1

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

12175630

1 reference

12 February 2018